Akut mieloid leukémia (AML): vizsgálatok itt: Oroszország
11 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
- Where
- Krasnogorsk, Moscow, Saint Petersburg, Velikiy Novgorod
- Életkor
- 18 év and over
- People
- 66 worldwide
- Run by
- Lomond Therapeutics Holdings, Inc.
See details and how to joinNCT07303660 - 2/3. fázisTaking peopleCo-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
- Where
- Moscow
- Életkor
- 1 év to 25 év
- People
- 64
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07366801 - 2. fázisTaking peopleFeasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
- Where
- Moscow
- Életkor
- 1 hónap to 25 év
- People
- 15
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07256210 - 3. fázisTaking peopleA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
- Where
- Moscow, Saint Petersburg
- Életkor
- 18 év and over
- People
- 486 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06389292 · EU 2024-516436-10-00 - 3. fázisTaking peopleThe Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia
- Where
- Moscow
- Életkor
- 1 nap to 18 év
- People
- 100
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07232134 - 2. fázisTaking peopleOptimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
- Where
- Saint Petersburg
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT07238712 - 2/3. fázisTaking peoplePreventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
- Where
- Moscow
- Életkor
- 1 nap to 21 év
- People
- 50
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06756152 - 2. fázisTaking peopleSorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
- Where
- Saint Petersburg
- Életkor
- 18 év to 75 év
- People
- 88
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06532084 - 2. fázisTaking peopleVitamin A and D Supplementation in Allogeneic HCT
- Where
- Saint Petersburg
- Életkor
- 18 év and over
- People
- 220
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06508099 - 2. fázisTaking peopleBeFluBu vs FluBuRux Conditioning in Haploidentical HCT
- Where
- Saint Petersburg
- Életkor
- 18 év to 75 év
- People
- 220
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06477549 - 3. fázisTaking peopleIMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML
- Where
- Moscow
- Életkor
- 18 év and over
- People
- 198
- Run by
- National Research Center for Hematology, Russia
See details and how to joinNCT06418776